Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Celgene Buys Gloucester Pharma
TheStreet.com
Monday, December 7, 2009 - 12:34pm
tags:
Celgene, Glouchester Pharma, M&A
Somaxon Plunges on U.S. Rejection of Insomnia Drug
Bloomberg
Monday, December 7, 2009 - 12:33pm
tags:
insomnia, Silenor, Somaxon, FDA
Santarus on a Roll
Yahoo/Zacks.com
Monday, December 7, 2009 - 12:32pm
tags:
Santarus, Merck, GSK, Zegerid
Amgen Off After $5B Buyback Plan
Barron's
Monday, December 7, 2009 - 12:28pm
tags:
Amgen, stock buyback
Bristol Amends and Extends Offer
Yahoo/Zacks.com
Monday, December 7, 2009 - 12:27pm
tags:
Mead Johnson, Bristol-Myers Squibb
Generic Drugs Continue To Accelerate Market Share Expansion According To Sanford Bernstein
Yahoo/Wall Street Transcript
Monday, December 7, 2009 - 12:25pm
tags:
generics, Impax Labs, Keryx, Rigel
Moment of Truth for Health Care
Yahoo/Morningstar
Monday, December 7, 2009 - 12:21pm
tags:
Merck, healthcare reform, GSK, Express Scripts
Introducing the $30,000 Per Month Cancer Drug
WSJ Online
Monday, December 7, 2009 - 12:20pm
tags:
cancer, Folotyn, lymphoma, Allos
Elan: J&J unit seeks Europe schizophrenia-drug OK
Marketwatch
Monday, December 7, 2009 - 12:19pm
tags:
Europe, schizophrenia, Elan, JNJ
Court Agrees Solvay Whistleblower Suit Should Be Tossed
Pharmalot
Monday, December 7, 2009 - 11:35am
tags:
Solvay, whistleblowers
Novo Starts First Insulin Pill Test in Bid to Replace Injection
Bloomberg
Monday, December 7, 2009 - 11:33am
tags:
Novo Nordisk, insulin, diabetes
Cephalon’s Treanda Poised for 10-Fold Sales Surge
Bloomberg
Monday, December 7, 2009 - 11:32am
tags:
Cephalon, Treanda, cancer
France Takes Another Shot at Combating H1N1 Threat
WSJ Online
Monday, December 7, 2009 - 11:31am
tags:
France, vaccines, swine flu, H1N1
Blood Thinner Battle Heats Up
Forbes
Monday, December 7, 2009 - 11:24am
tags:
Boehringer Ingelheim, JNJ, blood thinners
Cytokinetics Announces Clinical Trial Data Regarding SB-743921 Presented at the 2009 American Society of Hematology Annual Meeting and Exposition
Yahoo/MarketWire
Sunday, December 6, 2009 - 12:20pm
tags:
Cytokinetics, Hodgkin's lymphoma
Better Biotech Buy: Celgene or Genzyme?
Motley Fool
Sunday, December 6, 2009 - 12:18pm
tags:
Celgene, Genzyme
Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability
Trading Markets
Sunday, December 6, 2009 - 12:17pm
tags:
ONYX Pharmaceuticals, Carfilzomib, Multiple Myeloma
AstraZeneca Could Face 6,000 Lawsuits over Seroquel Side Effects
Lawyers and Settlements
Sunday, December 6, 2009 - 11:29am
tags:
AstraZeneca, Seroquel
Eshoo bill huge boon for Silicon Valley biotech
San Francisco Gate
Sunday, December 6, 2009 - 11:27am
tags:
biotech, Eschoo bill
Taro's first branded drug gets FDA trial nod
Globes, Israel
Sunday, December 6, 2009 - 11:17am
tags:
Taro, essential tremor, T2000

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.